Mereo BioPharma Group plc
MREO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $49 | $56 | $62 | $70 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $4 | $2 | $3 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $2 | $2 | $2 |
| Total Curr. Assets | $52 | $61 | $67 | $75 |
| Property Plant & Equip (Net) | $1 | $1 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $1 | $0 | $1 | $1 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $1 | $1 | $1 | $2 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $54 | $63 | $68 | $76 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $3 | $2 |
| Short-Term Debt | $0 | $1 | $1 | $6 |
| Tax Payable | $0 | $0 | $0 | $1 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $5 | $5 | $3 | $4 |
| Total Curr. Liab. | $6 | $8 | $7 | $14 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $1 | $1 | $1 |
| Total NC Liab. | $1 | $1 | $1 | $2 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $1 | $1 | $1 |
| Total Liabilities | $7 | $8 | $8 | $15 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $3 | $3 | $3 | $3 |
| Retained Earnings | -$494 | -$487 | -$472 | -$463 |
| AOCI | -$11 | -$9 | -$15 | -$19 |
| Other Equity | $548 | $546 | $544 | $540 |
| Total Equity | $47 | $54 | $60 | $61 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $54 | $63 | $68 | $76 |
| Net Debt | -$48 | -$56 | -$62 | -$63 |